ALTERNATIVE FINANCING FORMS
FOR ENTREPRENEURS AND INVESTORS

Author: Tatjana Anderer

Gründerin des FYB-Verlag
News

Colo­gne — Oppen­hoff advi­sed the BMV Group on its realignment and acqui­si­tion of the von den Hoff Group. The von den Hoff compa­nies will be taken over by a newly foun­ded subsi­diary, BMV Holding GmbH & Co. KG.

BMV Betei­li­gungs- und Besitz­ge­sell­schaft GmbH & Co. KG, head­quar­te­red in Hamburg, is an asso­cia­tion of medium-sized specia­list buil­ding mate­ri­als trading compa­nies. It main­ta­ins and estab­lishes part­ner­ship alli­ances with natio­nal and regio­nal suppli­ers. The share­hol­ders of the BMV Group are active throug­hout Germany.

The von den Hoff Group opera­tes specialty buil­ding mate­ri­als stores with loca­ti­ons in Düren, Aachen, Erft­stadt, Bonn and Sankt Augus­tin. It includes the roofing supplies Helmut von den Hoff GmbH & Co KG, H. von den Hoff GmbH & Co KG and J. Karl Voll­mar GmbH & Co. In addi­tion, a share in the alumi­num and steel profile system special whole­sa­ler HOBA Alu-Produkte Vertriebs GmbH belongs to the acqui­red group of companies.

By acqui­ring the compa­nies, which had previously been family-owned, the BMV Group was able to obtain a co-share­hol­der from its own circle and thus streng­then the diver­sity in the medium-sized buil­ding mate­ri­als trade.

“The tran­sac­tion is a novelty in the German Mittel­stand, as it is the first time that an alli­ance company acqui­res a member of its own. With this acqui­si­tion, Mittel­stand is secu­ring the diver­sity and contin­ued exis­tence of medium-sized buil­ders’ merchants,” says Dr. Phil­ipp Hein­richs, Junior Part­ner in the Corpo­rate Law / M&A depart­ment at Oppenhoff.

The Oppen­hoff team led by Dr. Phil­ipp Hein­richs (Corporate/M&A) included Marvin Roch­ner, Julia Höyng (both Real Estate), Dr. Daniel Dohrn, Renée Cherelle Eckruth (both Anti­trust), Marc Krischer and Hanjo Prond­zinski (both Tax). The exter­nal advi­sor was Ulrich Wald­schmidt (Dr. Gehre-Treu­hand GmbH).

About Oppen­hoff

The full-service law firm Oppen­hoff finds indus­try-speci­fic solu­ti­ons for groups, large owner-mana­ged compa­nies and finan­cial inves­tors. More than 100 attor­neys advise on all major areas of busi­ness and tax law.

News

Düssel­dorf — The share­hol­ders of m.Doc GmbH have sold 51% of the company to CompuGroup Medi­cal SE & Co. KGaA. ARQIS advi­sed m.Doc GmbH on this transaction.

m.Doc deve­lops pati­ent portals and other digi­tal appli­ca­ti­ons for clinics, reha­bi­li­ta­tion and care faci­li­ties. Foun­ded in 2016, the company has loca­ti­ons in Colo­gne and Lisbon and employs around 110 people. m.Doc’s focus is on digi­tiz­ing ever­y­day hospi­tal life, inte­gra­ting pati­ents into admi­nis­tra­tive and medi­cal proces­ses before, during and after inpa­ti­ent treat­ment, and provi­ding far-reaching relief and support for medi­cal staff. The tech­ni­cal basis for m.Doc’s appli­ca­ti­ons is the Smart Health plat­form, which combi­nes m.Doc’s modu­lar pati­ent portal with services such as video consul­ta­ti­ons, appoint­ment bookings, medi­ca­tion plans, treat­ment records and much more. The inter­ope­ra­bi­lity of the m.Doc plat­form with all common hospi­tal infor­ma­tion systems will be further advan­ced for the bene­fit of custo­mers and partners.

CompuGroup Medi­cal will further deve­lop m.Doc’s pati­ent portal and inte­grate it into its systems. In addi­tion, CompuGroup Medi­cal will expand the CLICKDOC solu­tion for appoint­ment bookings and video consul­ta­ti­ons and leverage syner­gies for messen­ger solu­ti­ons. The tran­sac­tion is an important mile­stone on the way to a fully digi­tal inpa­ti­ent and outpa­ti­ent pati­ent jour­ney and opti­mi­zes refer­rals from office-based physi­ci­ans to hospitals.

The ARQIS team around Jörn-Chris­tian Schulze has many years of expe­ri­ence in accom­pany­ing tran­sac­tions in the health­care and tech­no­logy sector. ARQIS was recom­men­ded by one of the share­hol­ders as advi­sor for the transaction.

Advi­sors to m.Doc GmbH: ARQIS (Düssel­dorf)
Dr. Jörn-Chris­tian Schulze, Foto (Lead; M&A), Thomas Chwa­lek (M&A); Coun­sel: Jens Knip­ping (Tax); Asso­cia­tes: Laura Ally Rizzi, Katrin Ludwig, Seve­rin Stef­fens (all M&A), Jasmin Grünen (Tax); Legal Specia­list: Qing Xia (M&A)

  • m.doc GmbH: Dr. Sabine Scholz, Head of Legal Department-
  • Flick Gocke Schaum­burg (Bonn): Dr. Phil­ipp Rulf (M&A), Dr. Thomas Belz (Tax)
  • Honert (Munich): Dr. Thomas Gräd­ler, LL.M. (taxes)
  • WMCF (Finan­cial Consul­ting, Munich): Ulf Böni­cke, Gerrit Hauck, Gian­marco Luso, Iuliana Bitca
News

Munich — Early­bird Venture Capi­tal has led a €3.2 million seed funding round for Berlin-based food tech startup Nosh.bio. In addi­tion to lead inves­tor Early­bird Venture Capi­tal, the Ameri­can fund Clear Current Capi­tal, Grey Silo Ventures and Good Seed Ventures parti­ci­pa­ted in the round. With the fresh capi­tal, Nosh.bio will conti­nue to commer­cia­lize its first product, deve­lop R&D proces­ses and expand produc­tion capacity.

Nosh.bio was foun­ded in 2022 by Tim Fron­zek, form­erly co-foun­der of rebuy.com, and Felipe Lino, former Novo­zy­mes rese­ar­cher and global R&D mana­ger at AB-InBev, with the goal of helping shape the food indus­try of tomor­row. The company uses natu­ral, fermen­ted myco­pro­tein to bring highly func­tional, healthy and clean-label ingre­di­ents to market at the same price as animal-based ingre­di­ents. Nosh.bio ingre­di­ents have binding, gelling and textu­ri­zing proper­ties and are expec­ted to replace chemi­cal addi­ti­ves in the future, enab­ling, for exam­ple, the produc­tion of meat substi­tute products with a single ingredient.

BMH BRÄUTIGAM conti­nuously advi­ses Early­bird on invest­ments (most recently on the finan­cing round of Green­lyte) and was able to further streng­then and expand the client relationship.

Advi­sor Early­bird: BMH BRÄUTIGAM

Bastian Rein­schmidt, Dr. Jan Böhle, Lisa-Marie Sarucco (all Venture Capital)

Advi­sor nosh.bio: Osborne Clarke

News

Munich, Germany — Ariceum Thera­peu­tics (Ariceum) successfully closes a Series A expan­sion finan­cing, raising an addi­tio­nal EUR 22.75 million for Ariceum on top of the EUR 25 million Series A finan­cing announ­ced in June 2022.

With this, Ariceum, a priva­tely held biotech­no­logy company based in Berlin, Germany, aims to advance its clini­cal pipe­line of next-gene­ra­tion radio­phar­maceu­ti­cals and further expand the company, with a focus on its proprie­tary peptide deri­va­tive sato­reo­tide, as well as a pipe­line of other projects. New inves­tors Andera Part­ners and Early­bird Venture Capi­tal join exis­ting inves­tor Pureos Bioven­tures in expan­sion financing.

Olivier Litzka from Andera Part­ners and Chris­toph Mass­ner from Early­bird Venture Capi­tal become addi­tio­nal members of Arice­um’s advi­sory board.

Baker McKen­zie advi­sed Ariceum Thera­peu­tics on all legal aspects rela­ted to the finan­cing. “Toge­ther with our client and our team of specia­li­zed corporate/M&A and life scien­ces lawy­ers, we have succee­ded in secu­ring further finan­cing for Ariceum, paving the way for the deve­lo­p­ment of thera­pies for pati­ents suffe­ring from certain diffi­cult-to-treat cancers,” commen­ted Julia Braun, LL.M., the lead part­ner on the transaction.

Legal advi­sor Ariceum Thera­peu­tics: Baker McKenzie

Lead: Julia Braun (Corporate/M&A, Part­ner, Munich)
Erik Kuhn (Asso­ciate, Munich), Anna Dzik (Asso­ciate, Munich)

About Baker McKenzie

Complex busi­ness chal­lenges require a holi­stic response across diffe­rent markets, sectors and juris­dic­tions. Baker McKen­zie’s solu­ti­ons for clients are accom­pa­nied by seam­less advice, under­pin­ned by in-depth prac­tice and indus­try know­ledge as well as excel­lent local market insights. In more than 70 offices world­wide, we work with our clients to provide solu­ti­ons for a connec­ted world.

News

Düssel­dorf — The Deloitte Legal team advi­sed Düssel­dorf-based RP Digi­tal GmbH, a subsi­diary of Rhei­ni­sche Post Medi­en­gruppe, on its 49 percent stake in best it AG.

Berlin-based best it AG digi­ti­zes busi­ness models and sales proces­ses of brands, manu­fac­tu­r­ers and retail­ers in both the B2B and B2C sectors in a sustainable and value-adding manner. It specia­li­zes in the deve­lo­p­ment and distri­bu­tion of soft­ware and licen­ses, as well as in consul­ting for compa­nies in the field of e‑commerce. In doing so, best it AG covers the entire value chain from e‑commerce, custo­mer enga­ge­ment, data & content manage­ment (PIM & CMS), UX & design to online marketing.

RP Digi­tal GmbH, the central digi­tal unit of Rhei­ni­sche Post Medi­en­gruppe, is expan­ding its digi­tal agency busi­ness with this tran­sac­tion to include the e‑commerce compo­nent. In the future, it will provide its regio­nal market part­ners with a digi­tal, scalable plat­form and deve­lop it further to offer the best custo­mer expe­ri­ence in the media busi­ness, dyna­mi­cally expand digi­tal custo­mer rela­ti­onships (end custo­mers and adver­ti­sers), and mone­tize them optimally.

Deloitte Legal provi­ded compre­hen­sive tran­sac­tional legal advice to RP Digi­tal GmbH. Rhei­ni­sche Post Medi­en­gruppe regu­larly relies on the support of Deloitte Legal for its M&A transactions.

Advi­sors RP Digi­tal GmbH: Deloitte Legal Germany
Dr. Michael von Rüden (Part­ner, Lead, Corporate/M&A), Thilo Hoff­mann (Part­ner, Corporate/M&A), Maxi­mi­lian Giep­mann (Asso­ciate, Corporate/M&A, all Düsseldorf)
Deloitte Legal Austria: Dr. Stefan Zischka (Part­ner), Chris­tina Feis­trit­zer (Asso­ciate, both Labor Law, both Vienna)

About Deloitte

Deloitte Legal refers to the legal advice prac­ti­ces of the member compa­nies of Deloitte Touche Tohmatsu Limi­ted, its affi­lia­tes or affi­lia­tes that provide legal services.
Deloitte provi­des indus­try-leading audit and assu­rance, tax, consul­ting, finan­cial advi­sory and risk advi­sory services to nearly 90% of Fortune Global 500® compa­nies and thou­sands of private compa­nies. Legal services in Germany are provi­ded by Deloitte Legal. Our people deli­ver measura­ble, long-term results that help build public confi­dence in the capi­tal markets, help our custo­mers trans­form and grow, and lead the way to a stron­ger economy, a more equi­ta­ble society, and a sustainable world. Deloitte builds on more than 175 years of history and opera­tes in more than 150 count­ries. Learn more about how Deloit­te’s more than 415,000 employees live the mission state­ment “making an impact that matters” every day: www.deloitte.com/de

News

Munich/ Martins­ried, Germany — Tubu­lis and Bris­tol Myers Squibb have ente­red into a stra­te­gic license agree­ment for the deve­lo­p­ment of diffe­ren­tia­ted anti­body-drug conju­ga­tes (ADCs). Under the terms of the license agree­ment, Bris­tol Myers Squibb will receive exclu­sive rights to Tubu­lis’ proprie­tary conju­ga­tion plat­forms for the deve­lo­p­ment of a select number of highly diffe­ren­tia­ted ADCs for the treat­ment of solid tumors. The agree­ment includes an upfront payment of $22.75 million to Tubu­lis and poten­tial mile­stone payments in excess of $1 billion for deve­lo­p­ment, regu­la­tory appr­oval and commer­cia­liza­tion, as well as royal­ties on the resul­ting marke­ted products.

Tubu­lis, based in Martins­ried, Germany, and Bris­tol Myers Squibb (BMS) intend to use the stra­te­gic part­ner­ship to further advance the deve­lo­p­ment of anti­body-drug conju­ga­tes (ADC). BMS will gain access to Tubu­lis’ proprie­tary P5 conju­ga­tion and Tubu­te­can plat­forms to deve­lop versa­tile and custo­mizable ADCs for cancer treatment.

The Tubu­lis P5 and Tubu­te­can plat­forms enable the produc­tion of ultra-stable ADCs with the poten­tial to actively reduce unwan­ted target-inde­pen­dent toxi­ci­ties. At the same time, they are opti­mi­zed for targe­ted deli­very of potent topoisomerase‑1 inhi­bi­tors. Follo­wing Bris­tol Myers Squib­b’s selec­tion of the target, Tubu­lis will provide the company with its linker payloads to gene­rate a uniquely matched ADC for each antibody.

Bris­tol Myers Squibb will assume sole respon­si­bi­lity for the deve­lo­p­ment, manu­fac­tu­ring and commer­cia­liza­tion of the resul­ting ADC candidates.

Almost exactly a year ago, m4 Award winner Tubu­lis had announ­ced a major success, successfully closing a Series B finan­cing of €60 million.

“This stra­te­gic agree­ment with Bris­tol Myers Squibb is an important vali­da­tion of the poten­tial of our approach to deve­lo­ping next-gene­ra­tion ADC-based thera­peu­tics and our state-of-the-art ADC conju­ga­tion tech­no­lo­gies that enable advan­ced ADC design to treat tumors with high unmet medi­cal need,” said Domi­nik Schu­ma­cher, M.D., CEO and co-foun­der of Tubu­lis. He sees the colla­bo­ra­tion with BMS as a signi­fi­cant step “in chan­ging onco­logy treat­ment para­digms and achie­ving better outco­mes for cancer patients.”

“ADCs play a promi­sing role in cancer therapy, and Tubu­lis’ diffe­ren­tia­ted tech­no­lo­gies offer oppor­tu­ni­ties to over­come current chal­lenges in deve­lo­ping safe and effec­tive ADC thera­peu­tics,” said Dr. Emma Lees, senior vice presi­dent, rese­arch and early deve­lo­p­ment and head of the Thema­tic Rese­arch Center for Mecha­nisms of Cancer Resis­tance at Bris­tol Myers Squibb.

News

Munich — The publicly traded Cana­dian company Constel­la­tion Soft­ware, Inc. acqui­red all shares in Peak­work AG in Düssel­dorf. Previous owners of Peak­work were company foun­der Ralf Usbeck and other members of the manage­ment team as majo­rity share­hol­ders as well as the private equity fund Brock­haus and TUI Betei­li­gungs GmbH. Finan­cial details of the acqui­si­tion were not disclosed.

Foun­ded in 2009, German company Peak­work deve­lops distri­bu­tion systems used by airlines, tour opera­tors and online travel agen­cies. Its product enables travel suppli­ers to access these services for sale to custo­mers. Peak­work, with appro­xi­m­ately 150 employees, will become part of Vela Soft­ware, one of Constel­la­tion Soft­ware’s six busi­ness units. The company will operate inde­pendently and stres­sed that there will be no inter­rup­tion of services.

Toronto-based Constel­la­tion is a publicly traded, global conglo­me­rate of soft­ware compa­nies in a variety of industries.

POELLATH provi­ded compre­hen­sive legal advice to the sellers in the context of the tran­sac­tion as lead coun­sel for the seller side with the follo­wing team:

Phil­ipp von Braun­schweig (photo), LL.M. (Ford­ham) (Part­ner, Lead Part­ner, Corporate/M&A, Munich)
Dr. Nico Fischer (Part­ner, Tax Law, Munich)
Daniel Wied­mann, LL.M. (NYU) (Asso­cia­ted Part­ner, Anti­trust Law, Frankfurt)
Dr. Andreas Reuther (Asso­cia­ted Part­ner, Employ­ment Law, Munich)
Chris­tine Funk, LL.M. (Coun­sel, IT, Frankfurt)
Dr. Matthias Meier (Senior Asso­ciate, M&A/Corporate, Munich)
David Lübke­meier, LL.M. (UCL) (Asso­ciate, Corporate/M&A, Munich)
Andreas Gesell (Asso­ciate, Tax Law, Munich)

POELLATH had alre­ady advi­sed inves­tor Brock­haus on its entry in 2017 and now recei­ved the trust of all sellers as lead coun­sel for the transaction.

Advi­sors to Constel­la­tion Soft­ware, Inc.: Taylor Wessing Hamburg
Dr. Jan Riebeling

Advi­sor TUI: Mayer Brown Düsseldorf
Dr. Jan Streer

As well as Mareike Acker­mann (in-house) involved.

News

Munich — We have Alpina Part­ners GmbH (“Alpina Part­ners”) has made a rele­vant invest­ment in FINA­plus GmbH (“FINA­plus”). Alpina Part­ners was advi­sed by OMMAX on this tran­sac­tion. FINA­plus is a soft­ware plat­form for asset manage­ment, consis­ting of PS plus Port­fo­lio Soft­ware + Consul­ting GmbH (“PSplus”) and Fina­Soft GmbH (“Fina­Soft”). The current manage­ment team will retain a signi­fi­cant stake in the company and support the next phase of FINA­plus’ growth.

The DACH wealth manage­ment soft­ware market is highly attrac­tive and is esti­ma­ted to grow at ~11% CAGR (2022F-26F). Posi­tive funda­men­tal drivers of the market include increased digi­tiza­tion ambi­ti­ons follo­wing the COVID-19 pande­mic and gene­ral indus­try trends.

To prepare for the invest­ment, OMMAX supported Alpina Part­ners through commer­cial and tech­ni­cal due dili­gence and exami­ned FINA­plus’ busi­ness model, market dyna­mics, compe­ti­tive land­scape, custo­mer perfor­mance and asses­sed manage­men­t’s busi­ness plan to derive actionable commer­cial and digi­tal value crea­tion oppor­tu­ni­ties. A tech­ni­cal stra­tegy and IT archi­tec­ture review were also conducted.

Florian Ewald, Part­ner at OMMAX: “FINA­plus has a strong, modern product offe­ring that serves many long-stan­ding custo­mer rela­ti­onships while having the poten­tial to successfully gain addi­tio­nal market share. We congra­tu­late Alpina Part­ners on being named to FINA­plus, a well-estab­lished company in the asset manage­ment soft­ware space.”

www.ommax.de

 

News

Berlin — Berlin-based deep-tech start-up Qdrant Solu­ti­ons GmbH has raised EUR 7.5 million in a seed finan­cing round that was seve­ral times over­sub­scri­bed. The round was led by Unusual Ventures. Green­Gate Part­ners compre­hen­si­vely advi­sed Qdrant Solu­ti­ons GmbH on the finan­cing round.

Qdrant Solu­ti­ons GmbH offers solu­ti­ons in the areas of Arti­fi­cial Intel­li­gence, Data Science, Machine Lear­ning, Big Data, Cloud Compu­ting and gene­ral soft­ware deve­lo­p­ment. Qdrant is a vector data­base and vectora simi­la­rity search engine. It is provi­ded as an API service that allows sear­ching for the nearest high-dimen­sio­nal vectors. With Qdrant, embed­dings or neural network enco­ders can be turned into full-fled­ged appli­ca­ti­ons for matching, sear­ching, recom­men­ding, etc.

The Berlin-based start-up, which was foun­ded at the end of 2021, had recei­ved EUR 2 million in pre-seed finan­cing from Euro­pean funds 42CAP and IBB Ventures at the begin­ning of last year. Just under 1.5 years after its foun­da­tion, the company has now been able to complete this extre­mely successful seed round. The round was over­sub­scri­bed seve­ral times, which is a great achie­ve­ment of the foun­ders and the employees of the company in the current market environment.

Green­Gate Part­ners compre­hen­si­vely advi­sed Qdrant Solu­ti­ons GmbH on the finan­cing round.

Advi­sor Qdrant Solu­ti­ons GmbH: Green­Gate Part­ners Rechts­an­walts­ge­sell­schaft mbH
Marc René Spitz, LL.M. (USC) (Lead; Part­ner, Corpo­rate) Dr. Leonie Singer, LL.M. (Asso­ciate, Corpo­rate) Constan­tin Forst­ner (Asso­ciate, Corporate)
Alex­an­der Tribess (Part­ner, IT & Data Protection)
Dr. Alex­an­der Raif (Part­ner, Labor Law)

Advi­sor to the main inves­tor Unusual Ventures: Good­win Proc­ter LLP Frankfurt
Dr. Gregor Klenk (Part­ner)
Chris­toph Hempel (Asso­ciate)

About Green­Gate Partners

Green­Gate Part­ners is a tech­no­logy law firm with parti­cu­lar exper­tise around venture capi­tal and tran­sac­tions. From our offices in Berlin, Hamburg and Munich, expe­ri­en­ced lawy­ers offer their clients first-class advice at eye level.
The scope of consul­ting in the venture capi­tal area is compre­hen­sive and ranges from the foun­da­tion to the indi­vi­dual finan­cing rounds to the exit. Clients include dome­stic and foreign venture capi­tal funds, stra­te­gic inves­tors, busi­ness angels as well as foun­ders, start-ups or managers.

News

Berlin — Hygraph has successfully closed a $30 million Series B invest­ment round led by One Peak to acce­le­rate the next gene­ra­tion of content manage­ment for the Composable Archi­tec­tures era.

Exis­ting inves­tors Open Ocean, One Peak, SquareOne and new busi­ness angel Boris Loks­hin (co-foun­der and CEO of Spry­ker Systems) also parti­ci­pa­ted in this new round, brin­ging our total funding to $43.7 million.

Foun­ded in 2017, Berlin-based startup Hygraph is an enter­prise content manage­ment plat­form that makes it possi­ble to deve­lop tomor­ro­w’s connec­ted digi­tal events quickly and at scale. Demand for networked digi­tal services is growing, but deve­lo­ping ever­y­thing indi­vi­du­ally is costly. Today, orga­niza­ti­ons not only need to distri­bute content across multi­ple devices, but also access and deli­ver content from a variety of discon­nec­ted sources.

Hygra­ph’s fede­ra­ted content plat­form repres­ents the next gene­ra­tion of content manage­ment, enab­ling a many-to-many rela­ti­onship between diffe­rent content sources and devices. Hygraph is head­quar­te­red in Berlin and employs 66 people from all over the world, spread over 5 conti­nents, 18 count­ries and 26 natio­na­li­ties. With the fresh capi­tal, Hygraph plans to conti­nue its inno­va­tion and expand its market presence, with a focus on North America.

“Just as Head­less CMS has trans­for­med content distri­bu­tion, Hygraph is trans­forming the inte­gra­tion of content and data to enable the crea­tion of new digi­tal services and busi­ness models in the content economy. Our new finan­cing round enables us to further scale our busi­ness. We want to do for content manage­ment what Mule­Soft has done for inte­gra­tion,” said Michael Luka­szc­zyk, CEO and co-foun­der of Hygraph.

Consul­tant Hygraph: Vogel Heerma Waitz

Dr. Simon Pfef­ferle (photo), Dr. Lorenz Frey, Dr. Jan Heerma and Maxi­mi­lian Göbel from the law firm Vogel Heerma Waitz advi­sed Hygraph on a series B finan­cing round with a total volume of USD 30 million. The finan­cing round was led by One Peak. Open Ocean, Peak, SquareOne and Boris Lokschin also participated.

About Vogel Heerma Waitz

Vogel Heerma Waitz is a Berlin-based law firm specia­li­zing in growth capi­tal, tech­no­logy and media.

News

Munich, Germany — MOVE, an Israel-based vaca­tion booking plat­form, today announ­ced that it has successfully raised €7 million in the first closing of its funding round. The invest­ment by inves­tors from Israel and promi­nent Munich-based family offices is expec­ted to acce­le­rate MOVE’s expan­sion into the Euro­pean market, follo­wing the company’s remar­kable success in the Israeli market. The invest­ment was broke­red by ennea capi­tal partners.

Laun­ched in Febru­ary 2022, MOVE’s ground­brea­king plat­form offers perso­na­li­zed, machine-cura­ted vaca­tion packa­ges that allow users to effort­lessly and quickly book custo­mizable leisure travel. In its first year of opera­tion, the company achie­ved €4 million in annual recur­ring reve­nue and €42 million in sales, proving the effec­ti­ve­ness of its tech­no­logy and busi­ness model.

Erez Bousso, CEO of MOVE, said, “We are thril­led with the confi­dence our inves­tors have placed in our vision and tech­no­logy. Their support will enable us to revo­lu­tio­nize the Euro­pean vaca­tion travel market and conti­nue to deli­ver outstan­ding value to our customers.”

With 300,000 monthly active users in Decem­ber 2022 and a 9/10 user refer­ral rate, MOVE plans to capture a signi­fi­cant share of the €350 billion addressa­ble market in Europe. The company’s manage­ment team consists of expe­ri­en­ced execu­ti­ves with proven track records at leading compa­nies such as lastminute.com, CWT and Expedia.

Günter Ehwei­ner, repre­sen­ta­tive of Roland Berger, one of the inves­tors, commen­ted, “MOVE’s plat­form is a game-chan­ger in the vaca­tion travel indus­try, offe­ring unmat­ched speed, conve­ni­ence and perso­na­liza­tion for custo­mers. We are exci­ted to invest in a company that is alre­ady show­ing impres­sive growth and has the poten­tial to change the way people book their vacations.”

MOVE’s plat­form connects depar­ture airports with city breaks and sun & beach vaca­tion desti­na­ti­ons, offe­ring custo­mers a 7 percent price advan­tage. The company’s omni-chan­nel marke­ting stra­tegy has resul­ted in market-leading Unit Econo­mics, with conver­sion rates two times higher and bookings five times faster than tradi­tio­nal platforms.

With an ambi­tious goal of achie­ving sales of more than €55 million by 2025, the company plans to use the funds raised to expand its presence in Europe, streng­then part­ner­ships with leading media houses and further deve­lop its state-of-the-art technology.

About MOVE
MOVE is a state-of-the-art vaca­tion booking plat­form that offers perso­na­li­zed, machine-cura­ted vaca­tion packa­ges. With a mission to revo­lu­tio­nize the travel indus­try, MOVE combi­nes tech­no­logy and conve­ni­ence to provide a seam­less expe­ri­ence for custo­mers seeking unique, custo­mizable leisure travel. For more infor­ma­tion, visit www.wearemove.io.

About ennea capi­tal partners
ennea is a leading M&A, invest­ment and advi­sory firm focu­sed on the Euro­pean travel indus­try. We are the part­ner of choice for foun­ders and inves­tors to acce­le­rate their ambi­ti­ons in buil­ding, scaling and selling market-leading companies.
www.ennea.vc

News

Berlin — Miss Sophie sells to Wilde­Group. Miss Sophie has writ­ten an impres­sive success story in 8 years, estab­li­shing itself as a direct-to-consu­mer pioneer in the beauty market. Sophie Kühn (photo, © Miss Sophie) foun­ded the company in Berlin in 2014, without inves­tors (“boot­strap­ped”) she scaled the company to an eight-figure turno­ver and counts almost one million custo­mers. Miss Sophie ranks first among the fastest growing online compa­nies in the beauty sector in Germany (Digi­tal 100 by similarweb).

During her semes­ter abroad in France, the busi­ness student came up with the idea for the nail foils. Since nail polish quickly peeled off her nails on the beach, she looked for an alter­na­tive — and found it. Sophie star­ted her busi­ness in her 1‑room apart­ment and packed the first orders there. In the early days of e‑commerce, the brand made a name for itself in the beauty world through nume­rous TV features. Influen­cer marke­ting paired with perfor­mance marke­ting allo­wed the company to grow sustainably.

The Miss Sophie product range consists of over 400 items: a variety of nail foils, access­ories for appli­ca­tion and removal, and care products. The beauty products are sold via the company’s own online store and via major beauty plat­forms such as Douglas, Flaconi, QVC, West­wing and Amazon. The nail foils are vegan and animal-free. The long shelf life of 14 days and easy appli­ca­tion make the nail foils so popu­lar with consumers.

Wilde­Group has been active in the cosme­tics indus­try for over 30 years, specia­li­zing in high-quality beauty products, services and trai­ning. Thanks to Wilde­Group’s long expe­ri­ence in the nail sector through its LCN as well as ales­san­dro brands and its opera­tio­nal resour­ces, Miss Sophie will be able to expand in its current markets, enter new markets, further deve­lop its B2B busi­ness and work on expan­ding its product range.

By part­ne­ring with Wilde­Group, foun­der Sophie Kühn is taking on a pionee­ring role. Because while the number of female foun­ders in Germany will rise to 20.3% in 2022 (source: Statista), only 4% of all exits in Europe are “women-led”, i.e. have at least one female foun­ding member (source: Deal­room; refers to exits with company valua­tion >$20m).

News

Gelsenkirchen/ Frank­furt and Munich — Smal­ler Mid-Cap Fund I (TSM I), advi­sed by Triton, has signed an agree­ment to sell Norres Bagger­man Group (“Norres Bagger­man”), a market-leading manu­fac­tu­rer of plas­tic hoses for indus­trial appli­ca­ti­ons in Europe, to Nalka DACH Invest­ments SA SICAF-RAIF (“Nalka”). Gibson, Dunn & Crut­cher LLP advi­sed Triton on this tran­sac­tion. The parties have agreed not to disc­lose details of the tran­sac­tion or the purchase price.

Norres Bagger­man is one of the Euro­pean leaders in the manu­fac­ture and tech­ni­cal instal­la­tion of indus­trial hose systems. The company employs around 400 people and has six produc­tion sites and 15 sales offices in Europe, the USA and Asia.

Triton acqui­red Norres Bagger­man in 2018 with the goal of deve­lo­ping the company into a Euro­pean market leader. To this end, growth was to be acce­le­ra­ted, inter­na­tio­nal expan­sion step­ped up and the company deve­lo­ped into a systems provi­der. As part of the Triton port­fo­lio, NORRES has successfully comple­ted three acqui­si­ti­ons, increased its orga­nic growth to appro­xi­m­ately 10%, and increased sales by more than 170% to well over €100 million. The company has also intro­du­ced a clearly defi­ned frame­work to further deve­lop its ESG standards.

Andi Klein, Mana­ging Part­ner and Head of TSM I: “We thank Ralf Dahmer, his manage­ment team and all employees of Norres Bagger­man for the great coope­ra­tion and their important contri­bu­tion to the deve­lo­p­ment of the company into a pan-Euro­pean market leader in its sector despite often uncer­tain times. We are convin­ced that NORRES is well posi­tio­ned for the future and that Nalka is the right part­ner to conti­nue the company’s success story.”

Since its foun­ding in 1997, Triton has laun­ched ten funds and focu­ses on invest­ments in medium-sized compa­nies head­quar­te­red in Europe in the indus­trial, services, consu­mer goods and health­care sectors. The current compa­nies in the Triton port­fo­lio gene­rate total sales of around 18 billion euros and employ over 105,000 people.

Advi­sor Triton: Gibson Dunn 

Led by Frank­furt part­ner Dr. Wilhelm Rein­hardt and Munich asso­ciate Dr. Dennis Seif­arth, the team included coun­sel Dr. Aliresa Fatemi and Anne­kat­rin Pels­ter and asso­cia­tes Dr. Mattias Prange and Lena Pirner (all Frank­furt) and Maxi­mi­lian Schnie­wind (Munich). The team also included part­ners Dr. Hans Martin Schmid (Tax, Munich) and Dr. Mark Zimmer (Labor Law, Munich), coun­sel Alex­an­der Klein (Finance, Frank­furt), and asso­cia­tes Jan Voll­kam­mer (Anti­trust, Frank­furt) and Yannick Ober­acker (Data Privacy/IP, Munich).

About Gibson Dunn

Gibson, Dunn & Crut­cher LLP is one of the leading inter­na­tio­nal law firms and is ranked among the top law firms world­wide in indus­try surveys and by autho­ri­ta­tive publi­ca­ti­ons. With more than 1,800 lawy­ers in 20 offices, the firm has a global presence in all major econo­mic regi­ons. Gibson Dunn offices are loca­ted in Abu Dhabi, Brussels, Century City, Dallas, Denver, Dubai, Frank­furt, Hong Kong, Hous­ton, London, Los Ange­les, Munich, New York, Orange County, Palo Alto, Paris, Beijing, San Fran­cisco, Singa­pore and Washing­ton, D.C. For more infor­ma­tion, visit www.gibsondunn.com.

News

Berlin — metr raised over six million euros, the company offers data-driven solu­ti­ons for a sustainable and digi­tal real estate indus­try. With the WIKA Group, the BraWo Group and Muji­nzo Labs GmbH, metr was able to gain three new inves­tors. In addi­tion, exis­ting inves­tors, such as Next Big Thing AG and early busi­ness angels, have increased their holdings.

A team led by Ariane Neubauer, Part­ner at Heuking Kühn Lüer Wojtek’s Berlin office, advi­sed metr Buil­ding Manage­ment Systems GmbH on its Series A finan­cing round.

“On the one hand, we will use the money from the Series A finan­cing round for further product deve­lo­p­ment and invest­ments in our plat­form. In this way, we will further digi­tize the real estate indus­try and thus come closer to our goal of signi­fi­cantly redu­cing CO2 emis­si­ons from buil­dings,” explains Dr. Franka Birke, CEO & Foun­der of metr. “The buil­ding sector is curr­ently under great pres­sure to act. The aim is to achieve climate targets, save energy and signi­fi­cantly increase energy effi­ci­ency, espe­ci­ally in exis­ting buil­dings. That’s why we will also use the cash injec­tion to expand our team to meet the increased demand.”

metr can look back on a very successful fiscal year 2022. The young company was able to triple its custo­mer base and expand its digi­tal plat­form for tech­ni­cal buil­ding equip­ment with addi­tio­nal part­ner solutions.

In view of the energy and climate crisis, the company has laun­ched another solu­tion to comple­ment the remote moni­to­ring of heating and drin­king water systems: AI-supported heating opti­miza­tion. Because, accor­ding to Dr. Franka Birke, it is beco­ming incre­asingly important for buil­ding owners and faci­lity mana­gers to reduce energy costs, save resour­ces and imple­ment effi­ci­ent, safe and sustainable buil­ding manage­ment. This also convin­ced the investors.

Advi­sors to metr Buil­ding Manage­ment Systems GmbH: Heuking Kühn Lüer Wojtek

Ariane Neubauer (lead; venture capi­tal), Astrid Reich (employ­ment law), Shimon Merkel (venture capi­tal), all Berlin

News

Düssel­dorf — A Deloitte Legal team has advi­sed Main Capi­tal port­fo­lio company Pro4all on its merger with PMG, a Munich-based German soft­ware provider.

Pro4all is a leading provi­der of docu­ment manage­ment, quality assu­rance and proac­tive risk manage­ment solu­ti­ons for the cons­truc­tion indus­try, based in the Nether­lands. The stra­te­gic merger with PMG is the first step in Pro4all’s inter­na­tio­nal buy-and-build stra­tegy since manage­ment teamed up with stra­te­gic soft­ware inves­tor Main Capi­tal Partners.

Munich — PMG was foun­ded in 2009 with head­quar­ters in Munich and is a leading soft­ware provi­der for the cons­truc­tion and real estate indus­try. The main product PAVE is a colla­bo­ra­tion plat­form for the entire life cycle of a cons­truc­tion project. The core of PAVE is a powerful and compre­hen­sive CDE (Common Data Envi­ron­ment), which is supple­men­ted with modu­les such as work­flows, project control, BIM, ESG, cost control­ling or cons­truc­tion docu­men­ta­tion. PMG serves more than 250 cons­truc­tion and real estate compa­nies, mainly in the DACH region, which curr­ently handle more than 1000 projects with PAVE.

Through the merger of Pro4all and PMG, the group will have a diver­si­fied custo­mer base of more than 1,000 play­ers in the cons­truc­tion and real estate indus­try. With a strong market presence in the Bene­lux and DACH regi­ons, the Group has a solid custo­mer base with an inter­na­tio­nal perspec­tive that can be lever­a­ged for expan­sion into other Euro­pean count­ries. In addi­tion, the compa­nies see oppor­tu­ni­ties for a strong and unique combi­ned product offe­ring that is well posi­tio­ned to support the cons­truc­tion indus­try in the digi­tiza­tion process. The combi­ned group curr­ently employs a total of 100 people.

The team led by Düssel­dorf-based Deloitte Legal attor­neys Felix Fell­ei­sen and Max Lüer­ßen has advi­sed Main Capi­tal on a number of plat­form and add-on tran­sac­tions and exits since 2015. As part of the stra­te­gic merger of Pro4all and PMG, the team was able to build in parti­cu­lar on its expe­ri­ence and exper­tise in deal­ing with German-Dutch constel­la­ti­ons as well as the inter­cul­tu­ral and lingu­i­stic skills of its Dutch-spea­king members.

Advi­sor Main Capi­tal: Deloitte Legal

Max Lüer­ßen, Foto (Coun­sel, Corporate/M&A, Düssel­dorf, Lead), Felix Fell­ei­sen (Part­ner, Corporate/M&A, Düssel­dorf, Co-Lead); Frauke Heudt­lass (Part­ner, Labor Law, Düssel­dorf); Dr. Fleur Johanna Prop, LL.M. (Coun­sel, Corporate/M&A, Düssel­dorf); Nicole Deneke, Nicole Rurik (Asso­cia­tes, Corporate/M&A, Düssel­dorf), Leonie Onkel­bach (Asso­ciate, Labor Law, Düsseldorf).

News

Düssel­dorf — Herbert Smith Freeh­ills has advi­sed Luft­hansa Group on the sale of its global cate­ring divi­sion LSG Group to private equity firm Aure­lius Group. Herbert Smith Freeh­ills alre­ady advi­sed Luft­hansa Group in 2019 on the sale of LSG Group’s Euro­pean busi­ness to Swiss-based Gategroup.

The carve-out tran­sac­tion includes all tradi­tio­nal cate­ring acti­vi­ties as well as the onboard retail and food commerce busi­nesses. The LSG Group has around 19,000 employees and consists of over 100 compa­nies opera­ting more than 130 service centers in the Ameri­cas (USA and Latin America), EMMA (emer­ging markets) and Asia-Paci­fic. LSG Group also includes onboard retail specia­list Retail InMo­tion and SCIS Air Secu­rity Services.

The tran­sac­tion invol­ves the trans­fer of shares and assets in more than 30 juris­dic­tions world­wide. The closing of the tran­sac­tion is subject to the neces­sary regu­la­tory appr­ovals and is expec­ted to take place in the third quar­ter of 2023.

LSG Group is head­quar­te­red in Neu-Isen­burg near Frank­furt am Main. In the pande­mic year 2021, it gene­ra­ted conso­li­da­ted sales of EUR 1.96 billion worldwide.

The Aure­lius Group is a private equity inves­tor based in Grün­wald, Germany. The invest­ment company curr­ently opera­tes in eight diffe­rent loca­ti­ons in Europe, inclu­ding Munich, London, Amster­dam, Stock­holm, Milan, Madrid, Luxem­bourg and Düsseldorf.

Advi­sor Deut­sche Luft­hansa: Herbert Smith Freehills

Düsseldorf/Frankfurt: Dr. Sönke Becker, Photo (Lead, Corporate/M&A), Dr. Marcel Nuys (Compe­ti­tion), Dr. Marius Boewe (Regu­la­tory), Dr. Stef­fen Hoer­ner (Tax), Kai Liebrich (Finance); Coun­sel: Dr. Chris­tian Johnen, Lena von Richt­ho­fen (both Corporate/M&A), Dr. Florian Huer­kamp (Compe­ti­tion), Dr. Hannes Jacobi (Finance); Asso­cia­tes: Dr. Niko­laus Moench, Marjel Dema, Janis Rentrop, Tobias Beuker, Dr. Marius Dicke (all Corpo­rate), Mirko Gleits­mann, Anne Ecken­roth, Caro­line Wendt (all Compe­ti­tion), David Rasche, Kris­tin Kattwin­kel (both Regu­la­tory), Wladi­mir Leon­hard, Tatiana Güns­ter (both Tax), Sophia Peter (Finance), Dr. Simone Zieg­ler (Data Protec­tion), Dr. Tim Abend­schein, Justus ter Veen (both Finance).

Hong Kong: Hilary Lau (Corpo­rate)
Johan­nes­burg: Rudolph du Ples­sis (Corpo­rate)
London: Mark Bardell (Corpo­rate), Kris­ten Roberts, Gabri­elle Wong (both Finance), Rachel Pinto (Pensi­ons)
New York: James Robin­son (Corpo­rate), Joseph Falcone, Jona­than Cross (both Regulatory)
Milan: Pietro Pouche (Dispu­tes)
Beijing: Nanda Lau (Corpo­rate)

 

News

New York & London — KKR, a leading global inves­tor, has announ­ced the final closing of Euro­pean Fund VI (the “Fund”). At $8.0 billion, inclu­ding the commit­ment from KKR itself, it is KKR’s largest Euro­pean private equity fund to date, follo­wed by the $6.6 billion fund laun­ched in 2019. The new fund will focus on private equity invest­ments, mainly in econo­mic­ally strong regi­ons of Western Europe.

Phil­ipp Freise Photo (© KKR), Co-Head of Euro­pean Private Equity at KKR, said, “KKR has been inves­t­ing in Europe for nearly 25 years and we believe the oppor­tu­ni­ties are grea­ter today than ever before. We believe the Euro­pean economy offers tremen­dous poten­tial for trans­for­ma­tive invest­ments in the context of struc­tu­ral trends, such as digi­ta­liza­tion, health­care and sustainability.”
Mattia Caprioli, Co-Head of Euro­pean Private Equity at KKR, added: “We look forward to support­ing foun­ders, family busi­nesses and corpo­ra­tes as a stra­te­gic part­ner helping them take their busi­ness to the next level.”

Chris­tian Ollig, Part­ner and Head of DACH at KKR, said: “Since 1999, we have inves­ted more than €15 billion in over 30 long-term orien­ted corpo­rate invest­ments in Germany, Austria and Switz­er­land. The DACH region is a key anchor for KKR in Europe, and our latest fund is a strong demons­tra­tion of our consis­tent commit­ment to the region. We look forward to the oppor­tu­ni­ties presen­ted by working with poten­tial part­ners and the resour­ces of the new fund.”

KKR’s success in Europe is based on a combi­na­tion of a strong local presence and exper­tise and access to a global network and resour­ces. More than 100 employees, inclu­ding 57 Euro­pean private equity execu­ti­ves, 25 members of KKR Capst­one Europe and other experts from KKR Capi­tal Markets, Public Affairs and the EMEA Macro team support the port­fo­lio compa­nies with their in-depth local market exper­tise. The team is repre­sen­ted in over eight diffe­rent Euro­pean offices and brings toge­ther a total of more than 15 Euro­pean natio­na­li­ties. This exper­tise is comple­men­ted by KKR’s global network. This draws on the know­ledge and skills of the KKR Global Insti­tute and KKR’s senior advi­sors, among others.

Alisa Amarosa Wood, Part­ner and Head of Global Private Markets and Real Assets Stra­te­gies Group at KKR, said, “We are plea­sed that our inves­tors share our Euro­pean team’s belief that there are excel­lent invest­ment oppor­tu­ni­ties in Europe. Many inves­tors have chosen not only to reinvest, but also to increase their expo­sure to our Euro­pean busi­ness. The place­ment of this fund in the current market envi­ron­ment demons­tra­tes the strong confi­dence inves­tors have in our Euro­pean team and plat­form, as well as our long track record of deli­ve­ring value and outstan­ding results.”

Through the fund, KKR will conti­nue to invest along­side family owners, foun­ders, entre­pre­neurs and compa­nies, provi­ding flexi­ble capi­tal for stra­te­gic part­ner­ships, plat­form expan­sion and carve-outs. In addi­tion to inves­tors, KKR itself will make a signi­fi­cant invest­ment in the fund, inves­t­ing a total of more than $1 billion in balance sheet funds and employee stock options.

KKR’s Euro­pean private equity plat­form curr­ently mana­ges total assets of $28.3 billion1 and is part of its $165 billion global private equity busi­ness. The current port­fo­lio includes invest­ments in over 45 compa­nies in Western Europe.

Debe­voise & Plimp­ton LLP acted as primary legal coun­sel to KKR in the fund­rai­sing process.

About KKR 

KKR is a leading global inves­tor provi­ding alter­na­tive asset manage­ment, capi­tal markets and insu­rance solu­ti­ons. The focus is on gene­ra­ting attrac­tive invest­ment returns through a long-term and disci­pli­ned invest­ment approach, employ­ing highly skil­led profes­sio­nals and support­ing growth at its invest­ment proper­ties and in the commu­ni­ties where KKR has a presence. KKR finan­ces funds that invest in private equity, credit products, real assets, and — through stra­te­gic part­ners — hedge funds.

News

Munich — The law firm Gütt Olk Feld­haus has advi­sed PLENTICON GROUP GmbH on the acqui­si­tion of the micro­PLAN Group. Plen­ti­con is a port­fo­lio company of Harald Quandt Indus­trie­be­tei­li­gun­gen GmbH.

The addi­tion of the Emsdet­ten-based IT systems house expands the group’s range of exper­tise, parti­cu­larly in the DATEV and data center areas as well as in DATEV consul­ting, while also incre­asing its geogra­phi­cal reach.

PLENTICON GROUP GmbH, head­quar­te­red in Frank­furt am Main, is one of the leading nati­on­wide full-service provi­ders for IT services. The majo­rity share­hol­der is Harald Quandt Indus­trie­be­tei­li­gun­gen GmbH (HQIB).

With around 120 employees at seven loca­ti­ons and its own data center, micro­PLAN is one of the largest IT inno­va­tion mana­gers in Germany. The port­fo­lio of the IT system house includes cloud services, ASP/IT outsour­cing, IT and DATEV solutions.

The GOF team led by part­ners Dr. Sebas­tian Olk (photo © GOF) and Dr. Tilmann Gütt advi­sed PLENTICON and Harald Quandt Indus­trie­be­tei­li­gun­gen GmbH on all tran­sac­tion-rela­ted legal issues as well as on the finan­cing. The law firm had previously advi­sed the group on the acqui­si­tion of System­haus Cramer GmbH, PK Office GmbH and Horn & Cosi­fan Compu­ter­sys­teme GmbH.

Legal advi­sors to Harald Quandt Indus­trie­be­tei­li­gun­gen GmbH and PLENTICON GROUP GmbH: Gütt Olk Feld­haus, Munich
Dr. Sebas­tian Olk (Part­ner, Corporate/M&A), Dr. Tilmann Gütt (Part­ner, Banking/Finance, both Lead), Thomas Becker (Of Coun­sel, IP/IT/Data Protec­tion), Isabelle Vran­cken, Dr. Domi­nik Forst­ner (both Senior Asso­cia­tes, Corporate/M&A), Chris­to­pher Krappitz (Asso­ciate, Banking/Finance)

Alten­burg Fach­an­wälte für Arbeits­recht, Munich
Andreas Ege, Dr. Char­lotte Beck, Henning Timm, Gero Thole (all labor law)

News

Munich — Global inves­tor River­side signs binding agree­ment to acquire leading clean­room consu­ma­bles compa­nies Dastex in Germany and Vita Verita in Sweden.

The River­side Company, the global inves­tor specia­li­zing in mid-market growth compa­nies, has signed an agree­ment to acquire Dastex Rein­raum­zu­be­hör GmbH & Co KG (Dastex), a leading specia­li­zed inde­pen­dent distri­bu­tor of clean­room appa­rel and consu­ma­bles in Europe. — In paral­lel, River­side signed an agree­ment to acquire Vita Verita, a leading company in the Swedish market, as the first exten­sion of the plat­form. The closing of the acqui­si­ti­ons is subject to custo­mary regu­la­tory approvals.

Foun­ded in Germany in 1979, Dastex has become a market-leading supplier of clean­room garm­ents and consu­ma­bles in Germany, Austria and Switz­er­land, with a strong foot­hold in the Bene­lux and a growing presence across Europe. The company has grown rapidly in recent years to meet strong demand from the phar­maceu­ti­cal and semi­con­duc­tor indus­tries, thanks to its unique tech­ni­cal know-how and rese­arch and deve­lo­p­ment exper­tise, compre­hen­sive product range and excel­lent custo­mer service.

Foun­ded in Sweden in 1983, Vita Verita is a specia­list in clean­room consu­ma­bles and labo­ra­tory equip­ment, air quality test­ing, service and main­ten­ance for phar­maceu­ti­cal compa­nies, hospi­tals and other control­led envi­ron­ments. The company offers both proprie­tary and third-party products, inclu­ding disposable garm­ents, gloves and wipes, as well as veri­fi­ca­tion and vali­da­tion services. Vita Verita can look back on nearly two deca­des of conti­nuous growth, supported by long-stan­ding custo­mer rela­ti­onships and a consis­tent focus on quality.

Damien Gaudin, Part­ner at River­side Europewho led the tran­sac­tions, commen­ted: “Through the acqui­si­tion of Dastex and Vita Verita, we combine two clean­room consu­ma­bles specia­lists in Europe that offer indis­pensable products and services and form the core of our pan-Euro­pean buy-and-build stra­tegy. This crea­tes a unique plat­form perfectly posi­tio­ned to grow further orga­ni­cally and through acqui­si­ti­ons. We look forward to working with the strong manage­ment teams of Dastex and Vita Verita to build the Euro­pean leader in clean­room conta­mi­na­tion control, offe­ring both best-in-class products and tech­ni­cal and regu­la­tory services, supported by an ambi­tious ESG strategy.”

Kars­ten Langer, Mana­ging Part­ner of River­side Europe, added, “The invest­ments unders­core River­side Euro­pe’s exper­tise at the inter­sec­tion of two of our focus sectors: Health­care and Specialty Distri­bu­tion. They are also a clear exam­ple of our pan-Euro­pean presence and our ability to build leading busi­nesses. Dastex and Vita Verita serve the conti­nuously growing clean­room indus­try, helping custo­mers in the phar­maceu­ti­cal, life scien­ces and other high-tech indus­tries to meet incre­asingly strin­gent quality and regu­la­tory stan­dards. The acqui­si­tion of Dastex and Vita Verita crea­tes a leader in clean­room conta­mi­na­tion control for the bene­fit of its customers.”

Cars­ten Mosch­ner, CEO of Dastex, commen­ted, “The manage­ment team and I are deligh­ted to join forces with Vita Verita and River­side to open the next chap­ter in the company’s history. I stron­gly believe that River­side is the ideal part­ner to support our ambi­tious growth plans and that the addi­tion of Vita Verita and their compre­hen­sive service offe­ring in Sweden is a criti­cal step in our jour­ney to become one of the pree­mi­nent provi­ders of conta­mi­na­tion control products and services in Europe. We look forward to further expan­ding our busi­ness across the conti­nent and provi­ding our custo­mers with an even broa­der full-service offe­ring. I would like to thank all employees, colle­agues, suppli­ers and custo­mers for their great support and trust.”

Anders Kumbrant, CEO, and Magnus Kumbrant, COO of Vita Verita, added: “We are deligh­ted to be working with Dastex and River­side to further realize our ambi­ti­ons and vision for the company. We are parti­cu­larly exci­ted at the pros­pect of working with Dastex, one of Euro­pe’s leading clean­room appa­rel and consu­ma­bles compa­nies, known for its outstan­ding exper­tise and profes­sio­na­lism. We would like to thank Anna-Lena Weiss, who will take a leading role at Vita Verita in the future, as well as the entire Vita Verita team, our custo­mers, suppli­ers and the River­side team for their trust and support.”

Working with Gaudin on the tran­sac­tion for River­side were Vice Presi­dent Maxime Meule­mees­ter, Senior Asso­ciate Nicola Tomaschko, Asso­cia­tes Sebas­tiaan Pauwels and Nils Mjörn­emark, and Origi­na­tion Asso­ciate Bence Putnoky. Damien Gaudin acqui­red the Dastex deal for River­side, while Ali Al Alaf and Nils Mjorn­emark acqui­red the Vita Verita deal.

Advi­sors to the share­hol­ders of the Dastex Group: McDer­mott Will & Emery, Frankfurt
Dr. Michael Cziesla, Norman Wasse, LL.M. (both Corporate/M&A, lead), Dr. Heiko Kermer, Marcus Fischer (Coun­sel; both Tax), Dr. Chris­tian Rolf, Dr. Gudrun Germa­kow­ski (Düssel­dorf; both Labor), Dr. Laura Stamm­witz (Coun­sel, Anti­trust), Dr. Deniz Tschamm­ler (Commercial/ Regu­la­tory, Frankfurt/Munich), Dr. Johan­nes Honzen (Real Estate); Asso­cia­tes: Dr. Marion von Grön­heim, Lisa Schick­ling (both Corporate/M&A), Lukas Deutz­mann (Cologne/Düsseldorf), Ilva Woeste (Munich; both Labor Law), Dr. Lea Hach­meis­ter, Alex­an­dra Heberle (both Healthcare/Regulatory)

dhmp Wirt­schafts­prü­fungs­ge­sell­schaft Steu­er­be­ra­tungs­ge­sell­schaft, Karls­ruhe, Germany
Nota­ries Dr. Frank and Dr. Schnee­weiß, Munich: Dr. Susanne Frank

About The River­side Company

The River­side Company is a global invest­ment firm focu­sed on invest­ments in middle-market growth compa­nies. Since its foun­ding in 1988, River­side has made more than 960 invest­ments. The firm’s inter­na­tio­nal private equity and struc­tu­red capi­tal port­fo­lios include more than 150 compa­nies. River­si­de’s Euro­pean opera­ti­ons are an inte­gral part of the company’s exten­sive global network which has been active in Europe since 1989. River­side belie­ves that an inter­na­tio­nal presence combi­ned with deep under­stan­ding of local condi­ti­ons, culture and busi­ness prac­ti­ces makes team members better inves­tors and busi­ness partners.
www.riversidecompany.com

News

Landshut/Munich — Munich-based elec­tric motor start-up Deep­Drive has successfully comple­ted a Series A finan­cing round of 15 million euros. In addi­tion to the exis­ting inves­tors Bayern Kapi­tal with its Bava­rian Growth Fund and UVC Part­ners, which came on board a year ago, BMW i Ventures and the Corpo­rate Venture Capi­tal Unit of Conti­nen­tal AG are also invol­ved. The company is also supported by the renow­ned auto­mo­tive mana­ger and former Audi board member for deve­lo­p­ment Dr. Peter Mertens. The addi­tio­nal funds are inten­ded to inten­sify the path taken to start large-scale produc­tion of the highly effi­ci­ent e‑motor and to be able to respond in terms of person­nel to the further increase in demand.

Foun­ded in 2021, Deep­Drive has deve­lo­ped a radial flux dual rotor motor inclu­ding power elec­tro­nics that can be instal­led in produc­tion vehic­les as a central drive as well as a wheel hub drive, setting enti­rely new stan­dards in e‑mobility. The paten­ted archi­tec­ture has a higher torque and power density compared to other drive tech­no­lo­gies and solves funda­men­tal problems of other e‑vehicle concepts. For exam­ple, a vehicle with Deep­Drive tech­no­logy can travel 20 percent further on a fully char­ged charge, or requi­res 20 percent smal­ler batte­ries than the compe­ti­tion for the same range, enab­ling the next gene­ra­tion of low-cost elec­tric vehic­les. Less rare earths are also used in produc­tion — a clear sustaina­bi­lity advan­tage. Deep­Drive is curr­ently alre­ady working with eight of the top ten auto­ma­kers on various deve­lo­p­ment projects and plans to bring the dual-rotor engine to market in large-scale produc­tion by 2026.

The Deep­Drive team is alre­ady working with eight of the top ten OEMs and is on track to bring its tech­no­logy into mass produc­tion by 2026. Deep­Drive co-foun­der and CEO Felix Pörn­ba­cher says: “The effi­ci­ency of e‑vehicles is one of the biggest chal­lenges facing almost all car manu­fac­tu­r­ers. With our double rotor drive, we have been able to deve­lop a key tech­no­logy that addres­ses precis­ely this problem and is thus attrac­ting extre­mely high inte­rest from indus­try. With our focus on disrup­tive inno­va­tion coupled with profes­sio­nal high-volume expe­ri­ence, we see oursel­ves as a pioneer of elec­tri­fi­ca­tion for mobi­lity. We look forward to working with our strong new part­ners and exis­ting support­ers to bring this tech­no­logy to the road and win initial volume projects.”

Bava­ria’s Minis­ter of Econo­mic Affairs Hubert Aiwan­ger: “Deep Drive’s busi­ness model is an excel­lent fit for Bava­ria as an auto­mo­tive loca­tion. There is great econo­mic poten­tial in the plat­form for the deve­lo­p­ment of elec­tric vehic­les. That is why we are support­ing the start-up with the Bava­ria 2 Growth Fund.”

“The use of Deep­Drive motors can save considera­ble costs — another step towards making e‑mobility more attrac­tive and cost-effec­tive and driving forward the all-important market pene­tra­tion,” says Monika Steger, Mana­ging Direc­tor of Bayern Kapi­tal. “We are plea­sed that the goal of scaling up to large-scale produc­tion in the near future has become a good deal more tangi­ble as a result of this new round of financing.”

About Bayern Kapital

Bayern Kapi­tal GmbH, based in Lands­hut, is the venture/growth capi­tal company of the Free State of Bava­ria. It accom­pa­nies inno­va­tive high-tech compa­nies in the Free State through various growth phases, from seed to later stage, with equity capi­tal in the amount of 0.25 to 25 million euros. Bayern Kapi­tal often fills gaps in the VC sector in proven consor­tium constel­la­ti­ons with private inves­tors (busi­ness angels, family offices and corpo­rate ventures).

Bayern Kapi­tal mana­ges specia­li­zed invest­ment funds with a volume of around 700 million euros. Since its foun­da­tion in 1995 on the initia­tive of the state govern­ment, the wholly owned subsi­diary of LfA Förder­bank Bayern has so far inves­ted around 400 million euros of its own equity capi­tal in around 300 start-ups and scale-ups in sectors such as life scien­ces, soft­ware & IT, mate­ri­als & new mate­ri­als, nano­tech­no­logy and envi­ron­men­tal tech­no­logy. As a result, more than 8,000 jobs have been perma­nently crea­ted in Bava­ria in sustainable compa­nies. The active port­fo­lio curr­ently compri­ses over 80 companies.
www.bayernkapital.de

About UVC

A tech team for tech teams. — We are rocket scien­tists, CS geeks, elec­tri­cal engi­neers, AI rese­ar­chers, mecha­ni­cal engi­neers, mate­ri­als scien­tists, and econo­mists. We value the entre­pre­neu­rial spirit, the pursuit of inno­va­tion and the pursuit of quality. Since 2011, we have built one of Euro­pe’s leading B2B venture capi­tal funds inves­t­ing across Europe from our offices in Berlin and Munich. As a team, we have made over one hundred B2B invest­ments with over thirty exits, inclu­ding some of our own compa­nies. https://www.uvcpartners.com

About BMW i VENTURES

Venture capi­tal for sustainable future tech­no­lo­gies and game chan­gers in mobi­lity. — Venture capi­ta­list BMW i Ventures invests in inno­va­tive, rapidly scaling start-ups from the auto­mo­tive envi­ron­ment that are helping to shape the indi­vi­dual mobi­lity of tomor­row. The focus is on tech­no­lo­gi­cal solu­ti­ons for the trans­por­ta­tion, manu­fac­tu­ring and supply indus­tries, as well as on inter­di­sci­pli­nary, sustainable solu­ti­ons. Thanks to its inde­pen­dence, BMW i Ventures makes invest­ment decis­i­ons quickly and in a manner appro­priate to the indus­try. This auto­nomy makes it possi­ble to match the speed and quality of the best venture capi­ta­lists and attract top invest­ment part­ners. The proxi­mity to the BMW Group in turn streng­thens the tech exper­tise of BMW i Ventures. https://www.bmwgroup.com/de/innovation/unternehmen/venturing_into_new_tech.html

News

Landshut/Ottobrunn — Isar Aero­space, deve­lo­per and manu­fac­tu­rer of launch vehic­les for the trans­port of small and medium-sized satel­li­tes, has secu­red addi­tio­nal capi­tal of 155 million euros in a Series C finan­cing round. The inter­na­tio­nal inves­tor base of this largest Space­Tech finan­cing round world­wide in 2023 includes Bayern Kapi­tal with ScaleUp Fonds Bayern as well as 7‑Industries Holding, Porsche SE, Early­bird Venture Capi­tal, HV Capi­tal, Lake­star, Lombard Odier, UVC and Vsquared Ventures. With total funding now in excess of €310 million, Isar Aero­space is the most stron­gly capi­ta­li­zed inde­pen­dent new-space company in Europe and a key player in streng­thening Euro­pean capa­bi­li­ties for consis­tent, flexi­ble and cost-effec­tive access to space for global commer­cial and insti­tu­tio­nal customers.

Isar Aero­space, based in Otto­brunn near Munich, deve­lops and builds launch vehic­les for trans­port­ing small and medium-sized satel­li­tes and satel­lite constel­la­ti­ons into Earth orbit. The company was foun­ded in 2018 as a spin-off from the Tech­ni­cal Univer­sity of Munich and has since estab­lished itself as a fully verti­cally inte­gra­ted tech­no­logy leader. Curr­ently, the more than 300 employees are working towards the first flight of the “Spec­trum” launch vehicle, which is plan­ned for the second half of 2023 from Andøya in Norway. In addi­tion, the “Aquila” engine, which was deve­lo­ped and manu­fac­tu­red enti­rely within the company, is curr­ently under­go­ing engine tests. In addi­tion to these projects, the addi­tio­nal funds from the finan­cing round will be used to inten­sify deve­lo­p­ment and to expand auto­ma­ted and thus cost-effi­ci­ent produc­tion capacities.

Isar Aero­space alre­ady has a strong custo­mer base and has signed firm contracts with custo­mers around the world, inclu­ding large commer­cial compa­nies, new-space firms and govern­ment insti­tu­ti­ons. Appli­ca­ti­ons for the satel­li­tes the company trans­ports into Earth orbit include envi­ron­men­tal moni­to­ring and protec­tion, Earth obser­va­tion, tele­com­mu­ni­ca­ti­ons, agri­cul­ture, disas­ter manage­ment, trans­por­ta­tion, scien­ti­fic rese­arch and security.

Daniel Metz­ler, co-foun­der and CEO of Isar Aero­space, explains: “The strong inte­rest of our inter­na­tio­nal inves­tors under­lines their confi­dence in our vision and tech­no­lo­gi­cal capa­bi­li­ties. Access to space is the key to inno­va­tion, tech­no­lo­gi­cal deve­lo­p­ment and secu­rity — alre­ady today and even more so in the future. Isar Aero­space opens up access to space, which is urgen­tly needed by commer­cial, insti­tu­tio­nal and govern­ment custo­mers. This funding round is an important mile­stone on our path to orbit.”

Bava­ria’s Minis­ter of Econo­mic Affairs Hubert Aiwan­ger: “Start-ups like Isar Aero­space are taking Bava­ria’s space tech­no­logy loca­tion to a new level. The company is an outstan­ding exam­ple: it offers important appli­ca­ti­ons such as climate obser­va­tion relia­ble and afforda­ble access to space. With our ScaleUp Fonds Bayern, we support such tech­no­logy leaders on their way to beco­ming inter­na­tio­nally active companies.”

Bayern Kapi­tal is one of the first venture capi­tal compa­nies to invest in the aero­space sector and is curr­ently invol­ved in Isar Aero­space custo­mer and vege­ta­tion obser­va­tion satel­lite deve­lo­per Orora­Tech, and drone start-up Quan­tum Systems, among others. Bayern Kapi­tal supports the various deve­lo­p­ment stages of young tech­no­logy compa­nies with seve­ral funds — the ScaleUp Fonds Bayern, laun­ched in 2021 with a total volume of 200 million euros, is a powerful finan­cing offer for parti­cu­larly rapidly expan­ding tech companies.

About Bayern Kapital
Bayern Kapi­tal GmbH, based in Lands­hut, is the venture/growth capi­tal company of the Free State of Bava­ria. It accom­pa­nies inno­va­tive high-tech compa­nies in the Free State through various growth phases, from seed to later stage, with equity capi­tal in the amount of 0.25 to 25 million euros. Bayern Kapi­tal often fills gaps in the VC sector in proven consor­tium constel­la­ti­ons with private inves­tors (busi­ness angels, family offices and corpo­rate ventures).

Bayern Kapi­tal mana­ges specia­li­zed invest­ment funds with a volume of around 700 million euros. Since its foun­da­tion in 1995 on the initia­tive of the state govern­ment, the wholly owned subsi­diary of LfA Förder­bank Bayern has so far inves­ted around 400 million euros of its own equity capi­tal in around 300 start-ups and scale-ups in sectors such as life scien­ces, soft­ware & IT, mate­ri­als & new mate­ri­als, nano­tech­no­logy and envi­ron­men­tal tech­no­logy. As a result, more than 8,000 jobs have been perma­nently crea­ted in Bava­ria in sustainable compa­nies. The active port­fo­lio curr­ently compri­ses over 80 companies.

Examp­les of nume­rous ground­brea­king success stories that Bayern Kapi­tal has been invol­ved in at an early stage include EOS (today the worl­d’s leading tech­no­logy provi­der in indus­trial 3D prin­ting of metals and plas­tics), Proglove, Fazua, SimS­cale, Scom­pler, egym, Parcel­lab, Cobrai­ner, Quan­tum Systems, Casavi, Riskme­thods, Tubu­lis, Cata­lym, Immu­nic, Sirion, tado and many more.
www.bayernkapital.de

News

Frank­furt a. Main — AnaCap and foun­ders sell mino­rity stake in MRH Trowe to TA Asso­cia­tes at 4.3 times multi­ple. Oppen­hoff advi­sed indus­trial insu­rance broker MRH Trowe on the mino­rity invest­ment by private equity inves­tor TA Asso­cia­tes. The tran­sac­tion is subject to clearance by the EU Commis­sion under merger control law. The parties have agreed not to disc­lose details of the transaction.

The new part­ner­ship with TA Asso­cia­tes will acce­le­rate MRHT’s impres­sive growth story and further cement the company’s posi­tion as one of the leading insu­rance brokers in the DACH region. With the entry of a further finan­cial inves­tor as a mino­rity share­hol­der, MRH Trowe is setting the course for the further growth of the group of compa­nies. Toge­ther with AnaCap Finan­cial Part­ners, which took a mino­rity stake in late 2020 as part of an initial growth plan, TA Asso­cia­tes will support the foun­ding and manage­ment team to further acce­le­rate the group’s growth trajec­tory. Even with the new US inves­tor, the manage­ment team remains the largest shareholder.

MRH Trowe is one of the ten largest German indus­trial brokers. Under the umbrella of Mester­heide Rockel Hirz Trowe AG Holding, MRH Trowe Insu­rance Brokers GmbH is joined by seve­ral specia­list service provi­ders for diffe­rent segments. MRH Trowe offers compre­hen­sive exper­tise in virtually all lines of insu­rance for indus­trial and commer­cial clients, insti­tu­ti­ons and upscale private clients. The owner-mana­ged company is pursuing a consis­tent growth course with a holi­stic range of consul­ting services, specia­li­zed teams of experts and a high degree of digi­tiza­tion at the inter­faces between clients, brokers and insu­r­ers. Around 1,100 employees manage a premium volume of more than 650 million euros.

TA Asso­cia­tes (TA) is a leading global private equity firm focu­sed on growing profi­ta­ble busi­nesses. Since 1968, TA has inves­ted in more than 560 compa­nies in five target indus­tries: tech­no­logy, health­care, finan­cial services, consu­mer products and busi­ness services. Through exten­sive indus­try know­ledge and stra­te­gic resour­ces, TA works with manage­ment teams around the world to help high-value compa­nies create lasting value. The company has raised $48.6 billion in capi­tal to date and has more than 150 invest­ment profes­sio­nals in offices in Boston, Menlo Park, Austin, London, Mumbai and Hong Kong.

AnaCap isa leading specia­list inves­tor in Euro­pean finan­cial, tech­no­logy and rela­ted busi­ness services, support­ing both foun­ders and entre­pre­neu­rial manage­ment teams. The focus is on acqui­si­ti­ons, manage­ment buy-ins or buy-outs of compa­nies that require capi­tal, know-how and expe­ri­ence to imple­ment orga­nic and inor­ga­nic stra­te­gies. Since 2005, the company has raised €2.7 billion in gross capi­tal and comple­ted 80 invest­ments in 16 Euro­pean count­ries. AnaCap insti­tu­tio­na­li­zes compa­nies and regu­larly execu­tes sophisti­ca­ted growth stra­te­gies such as buy-and-build programs that leverage a deep under­stan­ding of the sector.

Advi­sors to MRH Trowe: Oppenhoff

A team led by Dr. Markus Rasner (photo © Oppen­hpff) provi­ded compre­hen­sive advice. The other team included Till Liebau, Moritz Schmitz, Marcel Marko­vic (all Private Equity), Dr. Wolf­gang Kotzur (Finan­cing), Dr. Günter Seulen, Sebas­tian Gutmann, Moritz Bock (all Corpo­rate), Dr. Peter Etzbach, Thomas Wismann (both Insu­rance Regu­la­tory), Anja Dombrow­sky, Jenni­fer Bold (both Labor Law), Dr. Jürgen Hartung (IT and Data Protec­tion), Georg Leche­ler (IP), Dr. Hanna Schmidt (Commer­cial), Dr. Gunnar Knorr (Tax), Dr. Simon Spang­ler and Renée Cherelle Eckruth (both Merger Control). Advice on the tran­sac­tion and finan­cing was provi­ded jointly with the London office of Pros­kauer Rose.

Oppen­hoff & Part­ner Rechts­an­wälte Steu­er­be­ra­ter mbB (“Oppen­hoff”) is a part­ner­ship company regis­tered in the part­ner­ship regis­ter of the Essen Local Court with the regis­tra­tion number PR 1850 and its regis­tered office in Cologne. 

News

Kassel — The Kassel-based EAM Group has acqui­red Land­graf Ener­gie­tech­nik GmbH. As a future subsi­diary of the EAM Group, Land­graf Ener­gie­tech­nik, which has been family-owned until now, will contri­bute its compre­hen­sive exper­tise in the areas of sani­tary, heating and air condi­tio­ning (SHK). The tran­sac­tion is marked by the chal­lenges to be met in the course of the energy tran­si­tion. Oppen­hoff advi­sed the EAM Group on this transaction.

The medium-sized company Land­graf Ener­gie­tech­nik is a specia­li­zed service provi­der for sani­tary, heating and air condi­tio­ning tech­no­logy. The company, based in Schlitz (Hesse), offers a compre­hen­sive service for custo­mers in the private and public commer­cial, resi­den­tial and indus­trial cons­truc­tion sectors. Land­graf Ener­gie­tech­nik has distinc­tive exper­tise in the instal­la­tion of rege­ne­ra­tive heating systems such as wood boilers or heat pumps.

The muni­ci­pal energy supplier EAM, which has been in exis­tence since 1929, supplies energy to around 1.4 million people in the regi­ons of Hesse, Lower Saxony and parts of North Rhine-West­pha­lia, Rhine­land-Pala­ti­nate and Thurin­gia. The company acts as a part­ner for the energy tran­si­tion in the region and consis­t­ently pursues a sustainable course. In 2021, EAM gene­ra­ted sales of around one billion euros.

Advi­sor to the EAM Group: Oppenhoff
Lead part­ners Dr. Markus Rasner (M&A) ; Marcel Marko­vic (M&A), Anja Dombrow­sky, Corne­lia-Cris­tina Scupra (both Employ­ment), Marvin Roch­ner (Real Estate) and Dr. Gunnar Knorr (Tax).

Oppen­hoff regu­larly advi­ses compa­nies in the energy sector, most recently for exam­ple EnBW and Rhein­Ener­gie on the sale of their MVV shares to First State Invest­ments.

About Oppen­hoff

Oppen­hoff & Part­ner Rechts­an­wälte Steu­er­be­ra­ter mbB (“Oppen­hoff”) is a part­ner­ship company regis­tered in the part­ner­ship regis­ter of the Essen Local Court with the regis­tra­tion number PR 1850 and its regis­tered office in Colo­gne. A list of the part­ners autho­ri­zed to repre­sent the company is available at http://www.oppenhoff.eu/de/allgemeine-seiten/impressum.html. This message from Oppen­hoff is confi­den­tial and subject to attor­ney-client privi­lege. If you have recei­ved this message by mistake, please notify us imme­dia­tely and delete the message comple­tely from your system. Do not copy the message and do not make it available to anyone. All messa­ges sent or recei­ved by Oppen­hoff may be moni­to­red to ensure compli­ance with inter­nal poli­cies and rele­vant legis­la­tion. Emails are not secure and may contain errors as they may be inter­cepted, alte­red or destroyed, lost or contain viru­ses. Ever­yone who commu­ni­ca­tes with us through email accepts this risk.

News

Berlin — TX Ventures parti­ci­pa­tes in series A finan­cing round of Cash­link in the mid-seven-figure range. BMH BRÄUTIGAM advi­sed TX Ventures on this transaction.

FinTech company Cash­link provi­des the leading infra­struc­ture for asset toke­niza­tion, enab­ling fully digi­tal issu­ance of secu­ri­ties through the use of block­chain tech­no­logy. Cash­link was one of the first compa­nies to receive a provi­sio­nal permis­sion to regis­ter crypto-secu­ri­ties from the German Fede­ral Finan­cial Super­vi­sory Autho­rity (BaFin), allo­wing it to cover all neces­sary regu­la­tory requirements.

In addi­tion to lead inves­tor TX Ventures, Futury Capi­tal, Betei­li­gungs- Manage­ment­ge­sell­schaft Hessen, seve­ral busi­ness angels and exis­ting inves­tors inclu­ding C3 Venture Capi­tal, seed + speed, Panta Rhei and DEWB parti­ci­pa­ted in the finan­cing round. With the fresh capi­tal, Cash­link aims to streng­then its growth trajec­tory and expand its product offe­ring in terms of crypto-secu­ri­ties regis­try services.

About TX Ventures
TX Ventures is an inde­pen­dent FinTech VC inves­t­ing in the next gene­ra­tion of the
Finance inves­ted with the goal of beco­ming one of the leading early-stage inves­tors in
Europe in the topics FinTech, Insur­Tech & Crypto.

TX Ventures has made it its mission to invest in FinTechs that provide access to
Demo­cra­tize finan­cial products, empowe­ring people to make financial
secu­rity as well as improve effi­ci­ency and sustaina­bi­lity in the finan­cial area.
TX Ventures provi­des hands-on support to its compa­nies in the areas of marke­ting, tech
and cyber­se­cu­rity. TX Ventures is backed by TX Group, the largest private media group in Switz­er­land and a leading network of digi­tal platforms.
www.tx.ventures

About Futury Capital
Futury Capi­tal is an early-stage and growth inves­tor focu­sed on tech start­ups in
Germany and world­wide. The invest­ment universe covers seve­ral indus­tries such as
Tech­no­logy, soft­ware, consu­mer inter­net, arti­fi­cial intel­li­gence, fintech and more from and
helps compa­nies acce­le­rate their growth on their way to becoming
global market leaders. Through the LP struc­ture from the state of Hesse, family offices,
German SMEs and multi­na­tio­nal corpo­ra­ti­ons, Futury Capi­tal supports its
port­fo­lio compa­nies, both stra­te­gi­cally and opera­tio­nally, in the deve­lo­p­ment of
excep­tio­nal company.
https://www.futurycapital.vc

About BMH
BMH Betei­li­gungs-Manage­ment­ge­sell­schaft Hessen mbH, with its regis­tered office in Wies­ba­den, was
Foun­ded in 2001 and is a wholly owned subsi­diary of Landesbank
Hessen-Thürin­gen Giro­zen­trale (Helaba). About the Econo­mic and Infra­struc­ture Bank
Hesse (WIBank), BMH is actively invol­ved in the econo­mic deve­lo­p­ment of the state of Hesse.
inte­gra­ted. As a medium-sized invest­ment and venture capi­tal company, we combine
the BMH to manage the public parti­ci­pa­tion inte­rests and finan­cing instru­ments for
Early-stage, growth and medium-sized compa­nies in Hesse. The BMH manages
Curr­ently seven invest­ment funds with an inves­ted invest­ment volume of
a total of around 125 million euros. Since its foun­ding, BMH has been invol­ved in a total of more than
500 compa­nies inves­ted. The main areas of invest­ment include the sectors
Soft­ware & IT, Life Scien­ces, Engi­nee­ring, Indus­trial Goods, Professional
Services and e‑commerce. More infor­ma­tion about BMH and its funds:
www.bmh-hessen.de

About C3 Venture Capital
C3 Venture Capi­tal is a venture capi­tal firm that invests in exceptional
Block­chain tech­no­logy compa­nies inves­ted globally. The mission of C3 is to work under
among other things, the growth, deve­lo­p­ment and, above all, accep­tance of
Block­chain-based busi­ness models to acce­le­rate. The C3 Tech VC Fund
Focu­ses on early- and growth-stage tech­no­logy compa­nies and
usually takes a mino­rity share­hol­ding. C3 opera­tes world­wide and has its
Based in Frank­furt, Germany.
www.c3venturecapital.com

About DEWB
Deut­sche Effec­ten- und Wech­sel-Betei­li­gungs­ge­sell­schaft AG (DEWB AG, WKN: 804100 /
ISIN: DE0008041005) is a listed invest­ment company, which has its
invest­ment focus on asset manage­ment and busi­ness models, which are crucially
contri­bute to the digi­tiza­tion of this sector of the economy. In the last 20 years DEWB has
inves­ted more than 390 million euros in 65 compa­nies over the years, and with 50 exits, including
nine IPOs, reali­zed more than 500 million euros. With its over 200 years
corpo­rate history, DEWB stands for conti­nuity in the capi­tal market. Buil­ding on
This expe­ri­ence and a flair for future-orien­ted deve­lo­p­ments support the
DEWB provi­des its invest­ments with capi­tal, exper­tise in corpo­rate deve­lo­p­ment and
their wide-ranging network of experts.

About seed+speed Ventures
seed+speed Ventures is a pre-seed and seed inves­tor focu­sing on B2B soft­ware start­ups in the DACH region. The company invests in visio­nary foun­ders with promi­sing ideas for the future. In recent years, the port­fo­lio has grown to over 50 compa­nies, inclu­ding FinTech, Supply Chain, Cyber­se­cu­rity, EdTech nd Mobi­lity. — The foun­der is Cars­ten Maschmeyer. The entre­pre­neur, inves­tor, best-selling author, spea­ker and TV judge invests in start­ups in Europe and North America through his invest­ment compa­nies seed+speed Ventures, ALSTIN and Maschmeyer Group Ventures.

News

Landshut/Munich — Bayern Kapi­tal, one of the most expe­ri­en­ced and active inves­tors in the high-tech finan­cing land­scape, is inves­t­ing in mbio­mics GmbH. The Munich-based company is a pioneer in the field of micro­biome biotech­no­logy and is deve­lo­ping the first gene­ra­tion of effec­tive micro­biome-based live thera­peu­tics (LBT). In addi­tion to Bayern Kapi­tal, MIG Capi­tal as lead inves­tor as well as High-Tech Grün­der­fonds and other private inves­tors parti­ci­pa­ted in the first closing of the Series A round with a total volume of EUR 13 million. The closing of the funding round puts mbio­mics at the fore­front of the emer­ging field of synthe­tic micro­bial consor­tia, which have the poten­tial to revo­lu­tio­nize the treat­ment of a wide range of dise­a­ses, from cancer to inflamm­a­tory bowel disease.

Foun­ded in Munich in 2020, mbio­mics GmbH focu­ses on the deve­lo­p­ment of the first gene­ra­tion of effec­tive bacte­rial living thera­peu­tics (LBT). The company is using its proprie­tary, custom profil­ing plat­form and compu­ta­tio­nal tech­no­lo­gies to gene­rate high-reso­lu­tion precis­ion data to modu­late the micro­biota, over­co­ming current bott­len­ecks in LBT deve­lo­p­ment. The tech­no­logy enables a better under­stan­ding of the inter­ac­tions between the gut micro­biome and the host, allo­wing mbio­mics to deve­lop more effec­tive micro­bial consor­tia that can be deli­vered to pati­ents as precis­ion thera­pies. In addi­tion, mbio­mics’ core tech­no­logy impro­ves pati­ent selec­tion and moni­to­ring for clini­cal trials, crea­ting a compe­ti­tive advantage.

“The micro­biome offers a rich source of new thera­peu­tic oppor­tu­ni­ties that have not yet been fully explo­red. Our goal is to harness the power of the micro­biome to treat dise­a­ses that are diffi­cult to treat with conven­tio­nal approa­ches,” explains Dr. Markus Rinecker, co-foun­der and CMO of mbio­mics. “Our outstan­ding R&D team has deli­vered a tech­no­lo­gi­cal proof-of-concept for our analy­sis plat­form in record time. With this tech­no­logy, mbio­mics is uniquely posi­tio­ned to under­stand the modu­la­tion of the micro­biome and deve­lop effec­tive thera­pies,” added Johan­nes B. Woehr­stein, Ph.D., co-foun­der and CTO.

“We are very plea­sed to have the support of such a pres­ti­gious group of inves­tors who share our vision of harnes­sing the power of the gut micro­biome to deve­lop targe­ted thera­pies,” said Laura Figulla, Ph.D., co-foun­der and CEO of mbio­mics. “This funding will allow us to build our plat­form, acce­le­rate the selec­tion of our first lead product candi­da­tes, and inten­sify rese­arch acti­vi­ties with an eye toward clini­cal validation.”

“The influence of the micro­biome on dise­a­ses is curr­ently being rese­ar­ched in many ways,” said Monika Steger (photo © Bayern Kapi­tal), mana­ging direc­tor of Bayern Kapi­tal. “mbio­mics shows great poten­tial in the deve­lo­p­ment of micro­biome-based thera­peu­tics for support­ive inter­ven­tion in various dise­a­ses and can thus take rese­arch a decisive step forward. We look forward to pursuing this path toge­ther with the company and an expe­ri­en­ced and finan­ci­ally strong inves­tor consortium.”

Dr. Matthias Kromayer, Mana­ging Part­ner of MIG Capi­talcommen­ted: “We are plea­sed to announce our invest­ment in mbio­mics and to support the company on its jour­ney to deve­lop a powerful, inno­va­tive thera­peu­tics plat­form. The company’s approach of combi­ning new tech­no­lo­gies with cutting-edge micro­biome rese­arch is ground­brea­king and has the poten­tial to signi­fi­cantly improve treat­ment outco­mes for pati­ents. We look forward to support­ing mbio­mics’ ongo­ing rese­arch towards clini­cal development.”

“In the deve­lo­p­ment of “Live Bacte­rial Products”, micro­biome profil­ing remains one of the major chal­lenges. Mbio­mics has deve­lo­ped a novel high-perfor­mance profil­ing plat­form that addres­ses key bott­len­ecks in the deve­lo­p­ment of micro­biome-based thera­peu­tic approa­ches using novel bacte­rial consor­tia. We are plea­sed to invest in an excel­lent team and an inno­va­tive tech­no­logy toge­ther with strong co-inves­tors,” adds Dr. Jan Engels, Invest­ment Mana­ger at High-Tech Grün­der­fonds.

About Bayern Kapital
Bayern Kapi­tal GmbH, based in Lands­hut, is the venture/growth capi­tal company of the Free State of Bava­ria. It accom­pa­nies inno­va­tive high-tech compa­nies in the Free State through various growth phases, from seed to later stage, with equity capi­tal in the amount of 0.25 to 25 million euros. Bayern Kapi­tal often fills gaps in the VC sector in proven consor­tium constel­la­ti­ons with private inves­tors (busi­ness angels, family offices and corpo­rate ventures).

Bayern Kapi­tal mana­ges specia­li­zed invest­ment funds with a volume of around 700 million euros. Since its foun­da­tion in 1995 on the initia­tive of the state govern­ment, the wholly owned subsi­diary of LfA Förder­bank Bayern has so far inves­ted around 400 million euros of its own equity capi­tal in around 300 start-ups and scale-ups in sectors such as life scien­ces, soft­ware & IT, mate­ri­als & new mate­ri­als, nano­tech­no­logy and envi­ron­men­tal tech­no­logy. As a result, more than 8,000 jobs have been perma­nently crea­ted in Bava­ria in sustainable compa­nies. The active port­fo­lio curr­ently compri­ses over 80 companies.

Examp­les of nume­rous ground­brea­king success stories that Bayern Kapi­tal has been invol­ved in at an early stage include EOS (today the worl­d’s leading tech­no­logy provi­der in indus­trial 3D prin­ting of metals and plas­tics), Proglove, Fazua, SimS­cale, Scom­pler, egym, Parcel­lab, Cobrai­ner, Quan­tum Systems, Casavi, Riskme­thods, Tubu­lis, Cata­lym, Immu­nic, Sirion, tado and many more.
www.bayernkapital.de

About mbio­mics
Foun­ded in 2020 and head­quar­te­red in Munich, Germany, mbio­mics GmbH is a priva­tely held biotech company focu­sed on the deve­lo­p­ment of first gene­ra­tion effec­tive live bacte­rial thera­peu­tics (LBT). The company is lever­aging its custom micro­biome diagno­stics plat­form to over­come current bott­len­ecks in LBT deve­lo­p­ment — gene­ra­ting accu­rate profil­ing data, selec­ting better consor­tia, and impro­ving pati­ent stra­ti­fi­ca­tion and moni­to­ring in clini­cal trials.
www.mbiomics.com

News

Hamburg — Planet A Ventures was able to raise an invest­ment volume of € 160 million for its impact fund. Inves­tors include Alli­anz Invest­ment Manage­ment, BMW, KfW Capi­tal, REWE and the Danish state invest­ment fund Vaekst­fon­den. In addi­tion, the fund is supported by well-known serial entre­pre­neurs such as Rolf Schröm­gens (Triv­ago Co-Foun­der) Maxi­mi­lian Back­haus (Global CMO HelloFresh) and Rubin Ritter (Ex-Zalando Co-CEO).

The fund scores high on its scien­ti­fic approach to impact inves­t­ing. For exam­ple, Planet A Ventures has its own scien­ti­fic team that performs so-called “life cycle analy­ses” as part of the due dili­gence process. In addi­tion to CO2 emis­si­ons, this form of analy­sis also takes into account, among other things, biodi­ver­sity protec­tion, resource conser­va­tion and waste reduction.

About Planet A Ventures

Planet A Ventures is a venture capi­ta­list inves­t­ing in Euro­pean green tech start­ups that have a signi­fi­cant posi­tive impact on our planet. As a venture capi­ta­list, Planet A aims to contri­bute to an economy within plane­tary boun­da­ries. Planet A supports inno­va­tions in four key areas: Climate protec­tion, waste preven­tion, resource conser­va­tion and biodi­ver­sity protec­tion. As the first Euro­pean VC, Planet A bases its invest­ment decis­i­ons on scien­ti­fic life­cy­cle analy­sis and helps foun­ders scale their impact. Invest­ments include trace­l­ess mate­ri­als (plas­tic alter­na­ti­ves), Inera­tec (e‑fuels), C1 (green metha­nol), GA Dril­ling (geother­mal), 44.01 (carbon storage), and Maker­site (decar­bo­ni­zing supply chains).
www.planet‑a.com

Advi­sor Planet A Ventures: YPOG
Dr. Julian Albrecht (Structuring/Tax), Part­ner There­sia M. R. Hein­rich (Struc­tu­ring), Asso­ciate Lenn­art Lorenz (Regu­la­tory), Part­ner, Stefa­nie Nagel (Regu­la­tory), Senior Associate

News

Bruchsal/ Munich — SITA, the worl­d’s leading specia­list for commu­ni­ca­ti­ons and infor­ma­tion tech­no­logy in avia­tion, has joined Volo­c­op­ter as a new inves­tor in the Series E finan­cing round and will become its digi­tal and IT systems part­ner for vertiports.

SITA was selec­ted by Volo­c­op­ter as the prefer­red digi­tal and IT systems part­ner for Verti­ports. Under this agree­ment, SITA is the latest inves­tor to parti­ci­pate in Volo­c­op­ter’s Series E funding round, under­pin­ning the stra­te­gic vision of this part­ner­ship. A team led by Düssel­dorf-based Heuking part­ner Dr. Martin Imhof provi­ded legal advice to SITA on the successful invest­ment and conclu­sion of a stra­te­gic part­ner­ship with Volocopter.

Volo­c­op­ter is a pioneer in the field of urban air mobi­lity (UAM). The company is deve­lo­ping elec­tric verti­cal take-off passen­ger cabs (eVTOL) and cargo drones that will fly auto­no­mously. Volo­c­op­ter brings air mobi­lity to the worl­d’s mega­ci­ties, provi­ding sustainable and scalable UAM ecosys­tems with infra­struc­ture and opera­ti­ons part­ners to enable a new kind of trans­por­ta­tion. Volo­c­op­ter GmbH, head­quar­te­red in Bruch­sal, Germany, was foun­ded in 2011 and today employs more than 500 people in Germany and Singa­pore. The company has seve­ral inves­tors, inclu­ding Geely, NEOM, Merce­des-Benz Group, Intel Capi­tal, Honey­well and BlackRock.

In 2022, Volo­c­op­ter laun­ched a new Series E funding round to advance the global certi­fi­ca­tion process with EASA, FAA and other avia­tion autho­ri­ties, as well as the launch of commer­cial air taxi services in cities such as Singa­pore, Osaka, Rome and Paris.

SITA is the IT provi­der for the air trans­port indus­try, deli­ve­ring solu­ti­ons for airlines, airports, aircraft, govern­ments and inter­na­tio­nal orga­niza­ti­ons. The Group designs, deve­lops and supports tech­no­logy solu­ti­ons with the aim of faci­li­ta­ting all steps of an air jour­ney. SITA Group covers 95% of all inter­na­tio­nal desti­na­ti­ons and works with over 2,800 avia­tion and public sector custo­mers in all parts of the world. SITA employs more than 4,500 people and opera­tes in 126 count­ries worldwide.

Advi­sor to SITA: Heuking Kühn Lüer Wojtek
Dr. Martin Imhof (Lead Part­ner, Corporate/M&A),
Slaven Kova­ce­vic (co-lead, VC/PE),
Sebas­tian Poll­meier (Commer­cial and Corpo­rate Law),
Dr. Chris­tiane Vikto­ria Krumme (Corpo­rate Law/M&A),
Astrid Lued­tke (IT/IP),
Beatrice Stange, LL.M. (Anti­trust Law/Unfair Compe­ti­tion), all in Düsseldorf

News

Frank­furt a.M. — Vision Capi­tal and Rubicon Part­ners sell ABL-TECHNIC Group (ABL Group) to STAR Capi­tal Part­ner­ship LLP, STAR IV Fund. The manage­ment of the ABL Group reta­ins a stake in the company. The closing of the tran­sac­tion is subject to custo­mary regu­la­tory appr­ovals. McDer­mott Will & Emery advi­sed Vision Capi­tal and Rubicon Part­ners on this transaction.

Foun­ded in 1987, the ABL-TECHNIC Group is the worl­d’s largest paint strip­per with around 600 employees at 20 loca­ti­ons in ten count­ries. The company supplies over 7,000 custo­mers around the world and has a market share of appro­xi­m­ately 30% in Europe.

The McDer­mott team led by Dr. Michael Cziesla previously advi­sed Vision Capi­tal and Rubicon Part­ners on the acqui­si­tion of ABL Group.

Advi­sors Vision Capi­tal and Rubicon Part­ners: McDer­mott Will & Emery, Frankfurt
Dr. Michael Cziesla (lead), Dr. Chris­tian Marz­lin (Coun­sel), Ettore Scan­dale (Milan), Elea­nor West (London; all Corporate/M&A), Dr. Chris­tian Rolf (Labor Law), Dr. Deniz Tschamm­ler (Commercial/Regulatory, Frankfurt/Munich), Dr. Oliver Lieth (Finance, Düssel­dorf), Dr. Laura Stamm­witz (Coun­sel, Anti­trust), Dr. Heiko Kermer, Marcus Fischer (Coun­sel; both Tax); Asso­cia­tes: Isabelle Suzanne Müller, Lisa Schick­ling, Carlo Lemmi (Milan; all Corporate/M&A), Ilva Woeste (Labor Law, Munich), Matthias M. Bosbach (Finance, Düsseldorf).

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at] fyb.de

Send email